Matt Davids

Chadi speaks with Dr. Matt Davids, a hematology expert at Dana-Farber Cancer Institute and Harvard Medical School, known for his groundbreaking work on CLL therapies. They delve into the latest advancements in CLL treatment, highlighting the development of venetoclax. Dr. Davids shares his personal experiences from pivotal conferences and the excitement surrounding the drug's efficacy. The conversation also explores innovations in drug mechanisms and promising combination therapies that could redefine treatment paradigms for blood cancers.